Effect of glycemic control on electrophysiologic changes of diabetic neuropathy in type 2 diabetic patients

Kaohsiung Journal of Medical Sciences

Volumn 21, Issue 1, 2005, Pages 15-21

  Huang, Chun Chiang ^a   Chen, Tien Wen ^b   Weng, Ming Cheng ^b   Lee, Chia Ling ^a   Tseng, Hsiang Chieh ^b   Huang, Mao Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

Diabetic neuropathy; Nerve conduction velocity; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCENTAGE CHANGE; PERONEUS NERVE; SURAL NERVE; TIBIAL NERVE;

EID: 14144251218     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70271-2     Document Type: Article

References (22)

1. Lipnick JA, Lee TH. Diabetic neuropathy. Am Fam Physician 1996;54:2478-84.
2. Calissi PT, Jaber LA. Peripheral diabetic neuropathy: current concepts in treatment. Ann Pharmacother 1995;29:769-77.
3. Sangiorgio L, Lemmolo R, Le MR, et al. Diabetic neuropathy: prevalence, concordance between clinical and electrophysiological testing and impact of risk factors. Panminerva Med 1997;39:1-5.
4. Brown MJ, Ashbury AK. Diabetic neuropathy. Ann Neurol 1984;15:2-12.
5. Vinik AI. Diabetic neuropathy: pathogenesis and therapy. Am J Med 1999;107:17-26.
6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329: 977-86.
7. Tkac I, Bril V. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy. Diabetes Care 1998;21:1749-52.
8. Amthor KF, Dahl-Jorgensen K, Berg TJ, et al. The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo study. Diabetologia 1994;37:579-84.
9. Parry GJ. Management of diabetic neuropathy. Am J Med 1999; 107:27-33.
10. Sima AA, Nathaniel V, Bril V, et al. Histopathological heterogeneity of neuropathy in IDDM and non-IDDM, and demonstration of axo-glial dysfunction in human diabetic neuropathy. J Clin Invest 1988;81:349-64.
11. Dyck PJ, Karnes JL, O'Brien PC, et al. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 1992;42:1164-70.
12. Carrington AL, Shaw JE, Van Schie CH, et al. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 2002;25:2010-5.
13. rd edition. Philadelphia: Lippincott Williams & Wilkins, 2003.
14. Ziegle D, Mayer P, Muhlen H, et al. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycemic control during the first 5 years after diagnosis of type 1 diabetes mellitus. Diabetologia 1991;4:822-9.
15. Theriault M, Dort J, Sutherland G, et al. A prospective quantitative study of sensory deficits after whole sural nerve biopsies in diabetic and nondiabetic patients. Surgical approach and the role of collateral sprouting. Neurology 1998;50:480-4.
16. Veves A, Malik RA, Lye RH, et al. The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabet Med 1991; 8:917-21.
17. Thomas PK. Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes 1997;46:54-7.
18. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy: report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38:1456-61.
19. Forrest KY, Maser RE, Pambianco G, et al. Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes 1997;46:665-70.
20. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-24.
21. Pittenger GL, Liu D, Vlink AI. The apoptotic death of neuroblastoma cells caused by serum from patients with insulin-dependent diabetes and neuropathy may be Fas-mediated. J Neuroimmunol 1997;76:153-60.
22. Greene DA, Arezzo JC, Brown MB, et al. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology 1999;53:580-91.